HU229518B1 - Eljárás 13-cisz-retinsav elõállítására - Google Patents
Eljárás 13-cisz-retinsav elõállítására Download PDFInfo
- Publication number
- HU229518B1 HU229518B1 HU9901651A HUP9901651A HU229518B1 HU 229518 B1 HU229518 B1 HU 229518B1 HU 9901651 A HU9901651 A HU 9901651A HU P9901651 A HUP9901651 A HU P9901651A HU 229518 B1 HU229518 B1 HU 229518B1
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- acid
- mixture
- cis
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 28
- 238000002360 preparation method Methods 0.000 title claims description 9
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 title description 5
- 229960005280 isotretinoin Drugs 0.000 title description 3
- 239000000203 mixture Substances 0.000 claims description 26
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 22
- 239000002253 acid Substances 0.000 claims description 18
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 11
- 150000007513 acids Chemical class 0.000 claims description 7
- -1 halogen halide Chemical class 0.000 claims description 6
- 238000009833 condensation Methods 0.000 claims description 5
- 230000005494 condensation Effects 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 229910001385 heavy metal Inorganic materials 0.000 claims description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 3
- 229920002554 vinyl polymer Polymers 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000005977 Ethylene Substances 0.000 claims 2
- 239000000376 reactant Substances 0.000 claims 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- UCUUFSAXZMGPGH-UHFFFAOYSA-N penta-1,4-dien-3-one Chemical compound C=CC(=O)C=C UCUUFSAXZMGPGH-UHFFFAOYSA-N 0.000 claims 1
- 239000002516 radical scavenger Substances 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 7
- 229960001727 tretinoin Drugs 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- PZGYHDPZANRCSM-PKNBQFBNSA-N (1e)-3-methyl-1-(2,6,6-trimethylcyclohexen-1-yl)penta-1,4-dien-3-ol Chemical compound CC1=C(\C=C\C(C)(O)C=C)C(C)(C)CCC1 PZGYHDPZANRCSM-PKNBQFBNSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 229910052763 palladium Inorganic materials 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- INLLPKCGLOXCIV-UHFFFAOYSA-N bromoethene Chemical compound BrC=C INLLPKCGLOXCIV-UHFFFAOYSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 229930002330 retinoic acid Natural products 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000006317 isomerization reaction Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000003747 Grignard reaction Methods 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- RMGJCSHZTFKPNO-UHFFFAOYSA-M magnesium;ethene;bromide Chemical compound [Mg+2].[Br-].[CH-]=C RMGJCSHZTFKPNO-UHFFFAOYSA-M 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 150000004794 vinyl magnesium halides Chemical class 0.000 description 2
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 description 2
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 description 1
- XRNPHZPFAWLRNJ-UHFFFAOYSA-N 2-hydroxy-3-methyl-2h-furan-5-one Chemical compound CC1=CC(=O)OC1O XRNPHZPFAWLRNJ-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- FJPXXDHHAXYKFI-UHFFFAOYSA-N CC(CO)C=CO Chemical compound CC(CO)C=CO FJPXXDHHAXYKFI-UHFFFAOYSA-N 0.000 description 1
- 101150029590 CTSZ gene Proteins 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- UZFLPKAIBPNNCA-BQYQJAHWSA-N alpha-ionone Chemical compound CC(=O)\C=C\C1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-BQYQJAHWSA-N 0.000 description 1
- 150000001649 bromium compounds Chemical group 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000007699 photoisomerization reaction Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98MI001093A IT1299582B1 (it) | 1998-05-19 | 1998-05-19 | Procedimento per la preparazione dell'acido 13-cis-retinoico |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| HU9901651D0 HU9901651D0 (en) | 1999-07-28 |
| HUP9901651A2 HUP9901651A2 (hu) | 1999-12-28 |
| HUP9901651A3 HUP9901651A3 (en) | 2000-06-28 |
| HU229518B1 true HU229518B1 (hu) | 2014-01-28 |
Family
ID=11380052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9901651A HU229518B1 (hu) | 1998-05-19 | 1999-05-19 | Eljárás 13-cisz-retinsav elõállítására |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6177579B1 (es) |
| EP (1) | EP0959069B1 (es) |
| JP (1) | JP4418048B2 (es) |
| AT (1) | ATE226190T1 (es) |
| BR (1) | BR9901551B1 (es) |
| CA (1) | CA2272439C (es) |
| DE (1) | DE69903498T2 (es) |
| DK (1) | DK0959069T3 (es) |
| ES (1) | ES2185263T3 (es) |
| HU (1) | HU229518B1 (es) |
| IN (1) | IN188476B (es) |
| IT (1) | IT1299582B1 (es) |
| NO (1) | NO317759B1 (es) |
| PL (1) | PL192958B1 (es) |
| SG (1) | SG80628A1 (es) |
| ZA (1) | ZA993395B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7763748B2 (en) * | 2007-02-20 | 2010-07-27 | Ipca Laboratories Limited | Process for preparation of highly pure isotretinoin |
| CN104447459A (zh) * | 2014-11-28 | 2015-03-25 | 重庆华邦制药有限公司 | 异维a酸的新晶型及其制备方法与应用 |
| CN111454141A (zh) * | 2020-04-26 | 2020-07-28 | 上海新华联制药有限公司 | 一种异维a酸缩合物及其制备方法和应用 |
| CN116283495A (zh) * | 2021-12-01 | 2023-06-23 | 万华化学集团股份有限公司 | 一种乙烯基-β-紫罗兰醇的制备方法 |
| CN116462621A (zh) * | 2023-02-20 | 2023-07-21 | 湖北恒安芙林药业股份有限公司 | 一种维a酸的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3200231A1 (de) | 1982-01-07 | 1983-07-21 | Basf Ag, 6700 Ludwigshafen | (alpha)-pyrone und verfahren zur herstellung von polyencarbonsaeuren |
| DE4313089A1 (de) | 1993-04-22 | 1994-10-27 | Basf Ag | Verfahren zur Herstellung von 13-(Z)-Retinsäure |
| IT1289528B1 (it) | 1996-12-27 | 1998-10-15 | Lab Mag Spa | Procedimento per la preparazione dell'acido 13,cis-retinoico |
-
1998
- 1998-05-19 IT IT98MI001093A patent/IT1299582B1/it active IP Right Grant
-
1999
- 1999-05-17 CA CA2272439A patent/CA2272439C/en not_active Expired - Lifetime
- 1999-05-17 US US09/313,028 patent/US6177579B1/en not_active Expired - Lifetime
- 1999-05-18 IN IN566MA1999 patent/IN188476B/en unknown
- 1999-05-18 DE DE69903498T patent/DE69903498T2/de not_active Expired - Lifetime
- 1999-05-18 PL PL333200A patent/PL192958B1/pl unknown
- 1999-05-18 DK DK99109784T patent/DK0959069T3/da active
- 1999-05-18 ZA ZA9903395A patent/ZA993395B/xx unknown
- 1999-05-18 EP EP99109784A patent/EP0959069B1/en not_active Expired - Lifetime
- 1999-05-18 ES ES99109784T patent/ES2185263T3/es not_active Expired - Lifetime
- 1999-05-18 AT AT99109784T patent/ATE226190T1/de active
- 1999-05-19 BR BRPI9901551-0A patent/BR9901551B1/pt not_active IP Right Cessation
- 1999-05-19 JP JP13890999A patent/JP4418048B2/ja not_active Expired - Lifetime
- 1999-05-19 NO NO992396A patent/NO317759B1/no not_active IP Right Cessation
- 1999-05-19 SG SG9902501A patent/SG80628A1/en unknown
- 1999-05-19 HU HU9901651A patent/HU229518B1/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL333200A1 (en) | 1999-11-22 |
| HUP9901651A2 (hu) | 1999-12-28 |
| ES2185263T3 (es) | 2003-04-16 |
| JP2000034275A (ja) | 2000-02-02 |
| NO317759B1 (no) | 2004-12-13 |
| SG80628A1 (en) | 2001-05-22 |
| ATE226190T1 (de) | 2002-11-15 |
| HUP9901651A3 (en) | 2000-06-28 |
| EP0959069A1 (en) | 1999-11-24 |
| ITMI981093A1 (it) | 1999-11-19 |
| DK0959069T3 (da) | 2003-02-24 |
| NO992396L (no) | 1999-11-22 |
| ZA993395B (en) | 1999-11-18 |
| DE69903498T2 (de) | 2003-02-27 |
| NO992396D0 (no) | 1999-05-19 |
| JP4418048B2 (ja) | 2010-02-17 |
| BR9901551A (pt) | 2000-05-30 |
| US6177579B1 (en) | 2001-01-23 |
| IT1299582B1 (it) | 2000-03-16 |
| CA2272439C (en) | 2010-05-11 |
| IN188476B (es) | 2002-09-28 |
| BR9901551B1 (pt) | 2010-10-19 |
| PL192958B1 (pl) | 2006-12-29 |
| DE69903498D1 (de) | 2002-11-21 |
| CA2272439A1 (en) | 1999-11-19 |
| HU9901651D0 (en) | 1999-07-28 |
| EP0959069B1 (en) | 2002-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Alexakis et al. | Diastereoselective syn or anti opening of propargylic epoxides. Synthesis of α-allenic alcohols | |
| JPH0791244B2 (ja) | フルオキセチンの製造法 | |
| HU229518B1 (hu) | Eljárás 13-cisz-retinsav elõállítására | |
| US5196607A (en) | Process for preparing ketone enantiomer | |
| US2369161A (en) | Synthesis of vitamin a | |
| JPS6193136A (ja) | 環状オキソ化合物 | |
| US3852360A (en) | Preparation of hydroxycitronellal | |
| JP2018502886A (ja) | 多価不飽和ケトン化合物の製造方法 | |
| US3968163A (en) | Preparation of 4 and 5-methylindanes | |
| JP2838656B2 (ja) | ヒノキチオール及びその中間生成物の製造方法 | |
| US2369167A (en) | Synthesis of vitamin a | |
| US6201158B1 (en) | Process for making intermediate aldehydes | |
| EP0076448B1 (de) | Optisch aktive Bausteine für die Synthese der Seitenkette von (R,R,R)-Alpha-Tocopherol sowie Verfahren zu deren Herstellung | |
| US2369162A (en) | Synthesis of vitamin a | |
| JPH037245A (ja) | ２―オキソ―３―芳香族カルボン酸誘導体の製造方法 | |
| US3031512A (en) | Unsaturated aliphatic alcohols | |
| US3892814A (en) | Cyclopropane derivatives | |
| DE1793711B2 (de) | Verfahren zur Herstellung eines ungesättigten Aldehyds | |
| JP4366854B2 (ja) | １２−アミノ−４，８−ドデカジエンニトリル及びその製造法 | |
| JP2545289B2 (ja) | γーイオノン類の製造法 | |
| KR100570279B1 (ko) | 코엔자임 Ｑｎ의 중간체 및 그 중간체의 제조방법 | |
| JPH0147464B2 (es) | ||
| JPS6084241A (ja) | ４，６，８−トリメチルデカン−２−オン | |
| JPS63227562A (ja) | 環状テルペン化合物の異性化方法 | |
| Lee | The Rosenmund Reduction of 4-phenyl-3-butenoyl Chloride |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: OLON S.P.A., IT Free format text: FORMER OWNER(S): LABORATORI MAG S.P.A., IT; OLON S.P.A., IT |